Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis NWRN

Max Ratio

Dividend Yield

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History NWRN

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – CHF
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth NWRN

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin NWRN

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income NWRN

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM NWRN

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio NWRN

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Newron Pharmaceuticals SpA NWRN

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself NWRN

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 14.87
Forward PE 86.96
Enterprise Value Revenue 6.48
Price Sales TTM 6.29
Enterprise Value EBITDA 10.94
Price Book MRQ 239.55

Newron Pharmaceuticals SpA Dividends: – Yield, History, Payment Schedule

NWRN
Current price
18.28 CHF -0.3 CHF (-1.61%)
Last closed 18.52 CHF
ISIN IT0004147952
Sector Healthcare
Industry Biotechnology
Exchange SIX Swiss Exchange
Capitalization 378 555 807 CHF
Yield for 12 month +140.53 %
1Y
3Y
5Y
10Y
15Y
NWRN
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+48 186 394 CHF

Last Year

+8 492 394 CHF

Current Quarter

+11 156 289 CHF

Last Quarter

+44 991 783 CHF

Current Year

+48 186 394 CHF

Last Year

+8 492 394 CHF

Current Quarter

+11 156 289 CHF

Last Quarter

+44 991 783 CHF
EBITDA 35 372 124 CHF
Operating Margin TTM 11.30 %
Price to Earnings 14.87
Return On Assets TTM 50.97 %
PEG Ratio
Return On Equity TTM -839.80 %
Wall Street Target Price 14.52 CHF
Revenue TTM 60 149 888 CHF
Book Value 0.079 CHF
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 249.20 %
Dividend Yield
Gross Profit TTM 60 149 888 CHF
Earnings per share 1.28 CHF
Diluted Eps TTM 1.28 CHF
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY
Profit Margin 42.30 %

Technical Indicators NWRN

For 52 Weeks

5.22 CHF 19.81 CHF
50 Day MA 14.44 CHF
Shares Short Prior Month
200 Day MA 9.52 CHF
Short Ratio
Shares Short
Short Percent